PMH49 PREDICTORS OF TIME TO OUTPATIENT FOLLOW-UP AND COSTS AFTER HOSPITALIZATION AMONG MEDICAID BENEFICIARIES UTILIZING ORAL VERSUS LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN BIPOLAR DISORDER OR SCHIZOPHRENIA
May 1, 2020, 00:00
10.1016/j.jval.2020.04.668
https://www.valueinhealthjournal.com/article/S1098-3015(20)30856-1/fulltext
Title :
PMH49 PREDICTORS OF TIME TO OUTPATIENT FOLLOW-UP AND COSTS AFTER HOSPITALIZATION AMONG MEDICAID BENEFICIARIES UTILIZING ORAL VERSUS LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN BIPOLAR DISORDER OR SCHIZOPHRENIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30856-1&doi=10.1016/j.jval.2020.04.668
First page :
Section Title :
Open access? :
No
Section Order :
10557